Epoprostenol Sodium (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Epoprostenol Sodium drug offered from Teva Parenteral Medicines, Inc.. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: Epoprostenol Sodium
SUBSTANCE NAME: EPOPROSTENOL SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2008-04-23
END MARKETING DATE: 0000-00-00


Epoprostenol Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEpoprostenol Sodium from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2008-04-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0703-1985_45b8b475-ff2a-40c1-b330-0db3934d3e43
PRODUCT NDC: 0703-1985
APPLICATION NUMBER: ANDA078396

Other EPOPROSTENOL SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actelion Pharmaceuticals US, Inc.Veletri
GlaxoSmithKline LLCFLOLAN
Teva Parenteral Medicines, Inc.Epoprostenol Sodium